Difficulty Concentrating Mega Study
Contents
Difficulty Concentrating
Difficulty Concentrating

Related

A
1 to 5 Rating
A
Symptoms
A
Factors
A
Effects
A
User Variables 1
A
Measurements 13

Tags

Difficulty Concent
Difficulty Concentrating

Treatments Causing Difficulty Concentrating

User-reported treatments that exhibited the side effect of Difficulty Concentrating

Treatment Percent of Reports
Paroxetine 43%
Leuprolide 76%
Paroxetine (Paxil) 43%
Topiramate (Topamax) 70%

Below is the degree of change seen after Difficulty Concentrating is higher than average.

Below is the change in Difficulty Concentrating seen after the predictor is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.
Predictors
of
Below is the change in after the listed predictor is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change from the average seen after the predictor is higher than average.

Difficulty Concentrating Info

Property Value
Variable Name Difficulty Concentrating
Aggregation Method MEAN
Analysis Performed At 2020-09-15
Duration of Action 24 hours
Kurtosis 3.0892550140719
Maximum Allowed Value 5 out of 5
Mean 2.5185 out of 5
Median 2 out of 5
Minimum Allowed Value 1 out of 5
Number of Aggregate Predictors 1
Number of Aggregate Outcomes 16
Number of Measurements 13
Number of Measurements (including those generated by tagged, joined, or child variables) 13
Public true
Onset Delay 0 seconds
Standard Deviation 1.1560362248158
Unit 1 to 5 Rating
User Variables 1
UPC 0
Variable Category Symptoms
Variable ID 87185
Variance 1.3364197530864